Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Payables: 2024

Historic Payables for Kura Oncology (KURA) over the last 1 years, with Dec 2024 value amounting to $50.0 million.

  • Kura Oncology's Payables rose 80.67% to $66.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $214.8 million, marking a year-over-year change of. This contributed to the annual value of $50.0 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Kura Oncology reported Payables of $50.0 million as of FY2024.
  • Over the past 5 years, Kura Oncology's Payables peaked at $50.0 million during FY2024, and registered a low of $50.0 million during FY2024.
  • Moreover, its 1-year median value for Payables was $50.0 million (2024), whereas its average is $50.0 million.